Status:
UNKNOWN
Plant Extracted Natural Compounds Impact on Stage IV Breast Cancer Survival Time and Remission.
Lead Sponsor:
Brabant Research
Conditions:
Breast Cancer
Eligibility:
FEMALE
18-70 years
Brief Summary
RATIONALE: Plant extracted natural compounds, in an adjunct therapy position, slow the growth and reproduction of Stage IV Breast Cancer tumor cells. May help eradicate different types of cancers. PU...
Detailed Description
OBJECTIVES: To utilize multiple naturally-occurring bioalkaloids, bioactive "compounds of interest" from multiple sources, to influence prostate, breast, and uterine cancer pathways in cancer patient...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Diagnosis of prostate, breast, or uterine cancer
- Early or late stage disease
- Currently waiting to initiate conventional therapy or radiotherapy OR receiving concurrent conventional chemotherapy or radiation therapy
- Hormone receptor status not specified
- PATIENT CHARACTERISTICS:
- Menopausal status not specified
- PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
- Prior or concurrent chemotherapy or hormonal therapy for cancer allowed
Exclusion
Key Trial Info
Start Date :
September 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2021
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00910884
Start Date
September 1 2020
End Date
September 1 2021
Last Update
January 18 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brabant Research, Incorporated
Spokane Valley, Washington, United States, 99216